JF
SRPT icon

Jump Financial’s Sarepta Therapeutics SRPT Stock Holding History

Jump Financial’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
679,445
+171,617
+34% +$3.25M 0.1% 228
2026
Q1 		$11.1M Buy
507,828
+338,931
+201% +$6.56M 0.15% 154
2025
Q4 		$3.63M Sell
168,897
-132,112
-44% -$2.78M 0.04% 467
2025
Q3 		$5.8M Sell
301,009
-302,260
-50% -$5.39M 0.07% 366
2025
Q2 		$10.3M Buy
603,269
+597,484
+10,328% +$25.5M 0.11% 233
2025
Q1 		$369K Buy
5,785
+3,967
+218% +$418K ﹤0.01% 1206
2024
Q4 		$221K Buy
+1,818
New +$223K ﹤0.01% 1446
2024
Q3 		– Sell
-52,700
Closed -$8.33M – 2088
2024
Q2 		$8.33M Buy
+52,700
New +$6.77M 0.17% 113
2024
Q1 		– Sell
-14,077
Closed -$1.36M – 2281
2023
Q4 		$1.36M Buy
+14,077
New +$1.35M 0.04% 551
2023
Q3 		– Sell
-16,200
Closed -$1.86M – 2235
2023
Q2 		$1.86M Buy
16,200
+12,587
+348% +$1.62M 0.07% 422
2023
Q1 		$498K Sell
3,613
-34,282
-90% -$4.45M 0.02% 895
2022
Q4 		$4.91M Sell
37,895
-25,105
-40% -$2.91M 0.26% 100
2022
Q3 		$6.96M Buy
63,000
+703
+1% +$70.9K 0.27% 52
2022
Q2 		$4.67M Buy
+62,297
New +$4.58M 0.2% 125
2022
Q1 		– Sell
-5,055
Closed -$455K – 1892
2021
Q4 		$455K Buy
+5,055
New +$432K 0.03% 696
2021
Q2 		– Sell
-9,410
Closed -$701K – 1373
2021
Q1 		$701K Buy
+9,410
New +$868K 0.07% 317
2020
Q4 		– Sell
-3,560
Closed -$500K – 1165
2020
Q3 		$500K Buy
+3,560
New +$541K 0.1% 330

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jump Financial's SRPT Position: Q2 2026 in Review

Jump Financial increased its Sarepta Therapeutics (SRPT) stake by 34% in Q2 2026, buying an estimated $3.25M and bringing the position to 679,445 shares worth $12.2M. The position accounts for 0.1% of the portfolio, ranked #228.

Jump Financial first reported a position in SRPT in Q3 2020 and has held it in 17 quarters since. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Jump Financial held 679,445 shares of Sarepta Therapeutics worth $12.2M as of Q2 2026.
  • Jump Financial bought 171,617 Sarepta Therapeutics shares in Q2 2026, an estimated $3.25M.
  • Sarepta Therapeutics made up 0.1% of Jump Financial's portfolio in Q2 2026, its #228 holding.
  • Jump Financial first reported a position in Sarepta Therapeutics in Q3 2020 and has held it in 17 quarters since.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.